This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Functional Impact of GLP-1 for Heart Failure Treat...
Clinical trial

Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)

Read time: 2 mins
Last updated:1st Apr 2013

The primary objective is to test the hypothesis that, compared with placebo, therapy with Subcutaneous (SQ) GLP-1 agonist in the post-Acute Heart Failure Syndrome (AHFS) discharge period will be associated with greater clinical stability at six months as assessed by a composite clinical endpoint.

Category Value
Study type(s) Interventional
Expected enrolment 300
Study start date 2013-04-01
Estimated primary completion date 2015-10-01

View full details